• / Free eNewsletters & Magazine
  • / My Account
Home>Funds>Neuberger Berman High Yield Strategies

Neuberger Berman High Yield Strategies

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Tradeshift Listed as a Sample Vendor in Five Technology Categories in Gartner Hype Cycle for Procurement and Sourcing Solutions, 2015

    Tradeshift Listed as a Sample Vendor in Five Technology Categories in Gartner Hype Cycle for Procurement and Sourcing Solutions, 2015

  2. Research and Markets: Exocrine Pancreatic Insufficiency Global Clinical Trials Review, H1, 2015 - Clinical Trial Overview of Top Companies

    Research and Markets: Exocrine Pancreatic Insufficiency Global Clinical Trials Review, H1, 2015 - Clinical Trial Overview of Top Companies

  3. Research and Markets: Carotid Artery Stenosis 2015 - Clinical Trial Overview of Top Companies

    Research and Markets: Carotid Artery Stenosis 2015 - Clinical Trial Overview of Top Companies

  4. Genomic Health Announces Second Quarter 2015 Financial Results and Reports Record International and Prostate Cancer Tests Delivered

    Genomic Health Announces Second Quarter 2015 Financial Results and Reports Record International and Prostate Cancer Tests Delivered

  5. Neuberger Berman High Yield Strategies Fund Announces Monthly Distribution

    Neuberger Berman High Yield Strategies Fund Announces Monthly Distribution

  6. Japan Equity CEFs Win the First Quarter

    These closed-end funds were unstoppable in early 2015; plus, did the first IPO of 2015 usher in a new era for CEF shareholders?

  7. Observations about Neuberger Berman Closed-End Fund Tender Offers

    Dan Plettner invests and receives income for securities research, including “buy-side” research. Dan licenses his own real time trading data to Covestor Ltd. (“Covestor”), frequently including positions discussed in his Morningstar Contributions. Covestor is a Registered Investment Advisor that ...

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.